Isolated Limb Infusion (ILI)
New Inpatient Visitor Check-In Process Effective March 10. Learn more here.
New Inpatient Visitor Check-In Process Effective March 10. Learn more here.
The medical oncologists at Fox Chase Cancer Center are regional and national leaders in the treatment of skin cancer. As part of the multidisciplinary team, your medical oncologist will help to determine your personalized treatment plan, which may include systemic therapies, such as targeted therapy, immunotherapy, or chemotherapy, either as standard of care or as part of a clinical trial.
Metastatic melanoma (cancer that has spread to other parts of the body) is one of the hardest cancers to treat. Isolated Limb Infusion (ILI) is a minimally-invasive procedure for delivering high doses of chemotherapy directly to an arm or leg in people who have a type of metastatic melanoma called in-transit melanoma. By temporarily stopping blood flow to the affected limb, this technique allows the chemotherapy to concentrate where it is needed. Fox Chase in Philadelphia is one of the few cancer centers in the United States with the specialized skills needed to perform ILI. More than 60% of patients respond well to this treatment.
Isolated Limb Infusion (ILI)
In an Isolated Limb Infusion, a tourniquet is used to stop the blood circulation in the affected limb. A catheter is inserted into both the artery and vein and used to circulate a high dose of the treatment drug into the limb for up to 40 minutes, without the stress on other organs that would normally occur.
When the session is over, the drugs are flushed from the limb, and normal blood flow is returned. The full session can take three hours.
The ILI procedure can safely be repeated if deemed necessary.
Metastatic melanoma and extremity sarcoma are some of the hardest cancers to treat. Treatment for patients with advanced melanoma and sarcoma (that has spread to other parts of the body) may include surgery, radiation therapy, chemotherapy, interferon therapy, biologic/immunotherapy and/or innovative therapies using new drugs to fight the disease. ILI allows concentrated chemotherapy infusion with less strain on the patient. Collapse